Shobha Shukla - CNS
Covid-19 has posed innumerable health, economic, and social challenges for all, including people living with HIV. It has exposed the fragility of health systems around the globe and has diverted political attention and funding from other infectious diseases like TB and HIV. The opening session of the 11th International IAS Conference on HIV Science (#IAS2021) held virtually from Berlin, saw a lively panel discussing the tale of the two most horrendous recent pandemics in the history of our civilisation: Covid-19 and HIV/AIDS.
Dr Anthony Fauci, Director of National Institute of Allergies and Infectious Diseases, USA, said that we cannot forget HIV just because we happen to be in the middle of Covid-19. Decades of investment and science in HIV research, albeit as yet unsuccessful in developing an HIV vaccine, has played a major role in the development of highly successful Covid-19 vaccines in a very short period of time. But the fact that we have a
Tale Of Two Pandemics: Follow The Science And Do Not Forget One At The Cost Of The Other
scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.
Navi Mumbai: NMMC commences two phase survey to monitor Tuberculosis, Leprosy cases
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
Labs Worldwide Still Struggling Amid Broken Supply Chains
Countries outside the US and Europe that are already used to long wait times for laboratory supplies are facing greater research disruptions than ever during the pandemic.
May 21, 2021
Virologist Shi-Hsia Hwa of the Africa Health Research Institute in Durban, South Africa, holds up a multiwell plate used for plasma neutralization assays. The critical item in COVID-19 research has recently run low in supply at labs around the world.
Shi-Hsia Hwa, Africa Health Research Institute
Among the scientists across the world poised to rapidly produce data on SARS-CoV-2’s continued global proliferation is immunologist and virologist James Nyagwange of Kenya’s Medical Research Institute (KEMRI)-Wellcome Trust Research Program in Kilifi. He and his colleagues have planned a number of projects related to new variants and the human immune response to the virus, but over the past year, some of their COVID-19–related studies have